Document Type : Original Article

Authors

1 Master of Science , Department of Microbiology, Ayatollah AmoliBranch,Islamic Azad University, Amol, Iran

2 Assistant Professor, Department of Microbiology, Ayatollah AmoliBranch,Islamic Azad University, Amol, Iran

3 Assistant Professor, Biology Research Center, Imam Hossein Comprehensive University, Tehran, Iran

Abstract

Background: E. coli is one of the prevalent factors in human infections, especially urinary tract infections.Extended-spectrum ß-lactamase (ESBL) producing bacteria causes resistance to cephalosporin. Furthermore, the enzyme with the origin of plasmid causes the bacterial resistance to beta-lactam antibiotics. The aim of this study was to determine antibiotic susceptibility patterns and prevalence of CTX-M-type ESBL in E. coli strains isolated from urine samples by phenotypic and genotypic methods.
Methods: This descriptive, cross-sectional study of six-month duration (from December to April 2016) was undertaken to investigate patients’ antibiotic susceptibility. To fulfill that purpose, the urine samples of patients referred to seven clinics of the armed forces of the Mazandaran province were collected and antibiotic susceptibility of isolates by disk diffusion method on Mueller-Hinton agar was tested. To do confirmatory tests, the combined disk test method was performed. The test results were compared using standards Clinical and Laboratory standards (CLSIS). Ultimately, after DNA extraction by PCR method, isolates of ESBL positive for the presence of the CTX-M gene were examined and data were analyzed with SPSS software.
Results: Of the total 180 patients, 41 isolates of Escherichia coli were separated. From those, 21 isolates (51.21%) had produced ESBL. In PCR, 4(9.75%) of the ESBL positive isolates contained CTX-M gene. The highest resistance to antibiotics was observed for ampicillin (75.6%), cefalotin (58.5%), and cefazolin (60.9%) and the highest amount of sensitivity to antibiotics was seen for imipenem (75.6%), gentamicin (70.7%), and cefotaxime (60.9%).
Conclusion: Based on the observed high percentage of resistance to the third-generation-sfalspvryn, it is vitally important to perform precise and accurate antibiogram. Avoiding excessive over-prescription of antibiotics for infections caused by ESBL-producing organism is an inevitable necessity.

Keywords

  1. Nicolle LE. Uncomplicated urinary tract infection in adults including uncomplicated pyelonephritis. Urol Clin North Am. 2008;35:1-12.
  2. Amdekar S, Singh V, Singh DD. Probiotic therapy: immunomodulating approach toward urinary tract infection. Curr Microbiol. 2011;63:484.
  3. Wiener J, Quinn JP, Bradford PA, Goering RV, Nathan C, Bush K, et al. Multiple antibiotic–resistant Klebsiella and Escherichia coli in nursing homes. Jama. 1999;281:517-23.
  4. Raveh D, Yinnon AM, Broide E, Rudensky B. Susceptibilities of ESBL-producing Enterobacteriaceae to ertapenem, meropenem and piperacillin-tazobactam with and without clavulanic acid. Chemotherapy. 2007;53:185-9.
  5. Matthew M. Plasmid-mediated β-lactamases of gram-negative bacteria: properties and distribution. J Antimicrob Chemother. 1979;5:349-58.
  6. Sidjabat HE, Paterson DL, Adams-Haduch JM, Ewan L, Pasculle AW, Muto CA, et al. Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania. Antimicrob Agents Chemother. 2009;53:4733-9.
  7. Khalaf NG, Eletreby MM, Hanson ND. Characterization of CTX-M ESBLs in Enterobacter cloacae, Escherichia coli and Klebsiella pneumoniae clinical isolates from Cairo, Egypt. BMC infect dis. 2009;9:84.
  8. Moubareck C, Daoud Z, Hakimé NI, Hamzé M, Mangeney N, Matta H, et al. Countrywide spread of community-and hospital-acquired extended-spectrum β-lactamase (CTX-M-15)-producing Enterobacteriaceae in Lebanon. J Clin Microbiol. 2005;43:3309-13.
  9. Poirel L, Decousser J-W, Nordmann P. Insertion sequence ISEcp1B is involved in expression and mobilization of a blaCTX-M β-lactamase gene. Antimicrob Agents Chemother. 2003;47:2938-45.
  10. Mohajeri P, Izadi B, Rezai M, Falahi B, Khademi H, Ebrahimi R. Assessment of the frequency of extended spectrum beta lactamases producing Escherichia coli isolated from Urinary tract infections and its antibiotic resistance pattern in kermanshah. J Ardabil Univ Med Sci. 2011;11:86-94.
  11. Kurokawa H, Shibata N, Doi Y, Shibayama K, Kamachi K, Yagi T, et al. A new TEM-derived extended-spectrum β-lactamase (TEM-91) with an R164C substitution at the Ω-loop confers ceftazidime resistance. Antimicrob Agents Chemother. 2003;47:2981-3.
  12. Paterson DL, Bonomo RA. Extended-spectrum β-lactamases: a clinical update. Clin Microbiol rev. 2005;18:657-86.
  13. Petroni A, Corso A, Melano R, Cacace ML, Bru AM, Rossi A, et al. Plasmidic extended-spectrum β-lactamases in Vibrio cholerae O1 El Tor isolates in Argentina. Antimicrob Agents Chemother. 2002;46:1462-8.
  14. Celenza G, Pellegrini C, Caccamo M, Segatore B, Amicosante G, Perilli M. Spread of bla CTX-M-type and bla PER-2 β-lactamase genes in clinical isolates from Bolivian hospitals.J Antimicrob Chemother. 2006;57:975-8.
  15. Winokur P, Canton R, Casellas J-M, Legakis N. Variations in the prevalence of strains expressing an extended-spectrum β-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis. 2001;32:S94-S103.
  16. Quinteros M, Radice M, Gardella N, Rodriguez M, Costa N, Korbenfeld D, et al. Extended-spectrum β-lactamases in Enterobacteriaceae in Buenos Aires, Argentina, public hospitals Antimicrob Agents Chemother. 2003;47:2864-7.
  17. Pallecchi L, Malossi M, Mantella A, Gotuzzo E, Trigoso C, Bartoloni A, et al. Detection of CTX-M-type β-lactamase genes in fecal Escherichia coli isolates from healthy children in Bolivia and Peru. Antimicrob Agents Chemother. 2004;48(12):4556-61.
  18. Azarsa M, Shirazi M, Rastegar Lari A, Owlia P, Molla Aghamirzaei H, Sabbaghi A, et al. The frequency of extended spectrum beta lactamase and CTX MI of Escherichia coli isolated from the urine tract infection of patients by phenotypic and pcr methods in the city of khoy in iran. ZUMS Journal. 2011;19:53-61.
  19. Yazdi M, Nazemi A, Mir Inargasi M, Khataminejad MR, Sharifi S, M. BK. Prevalence of shv/ctx-m/tem (esbl) beta-lactamase resistance genes in Escherichia coli isolated from urinary tract infections in tehran, iran. Med Lab J. 2010;4:7.
  20. Zaboli F, Mahdipour Mir SM. Evaluation of antibiotic resistance and CTX-M gene in ESBL-producing Escherichia coli by PCR among urine samples of patients reffering to Yahyanejad hospital of Babol city, Iran. Hakim Jorjani J. 2017;4:34-47.
  21. Haghighatpanah M, Amirmozafari N, Faezi M, Shenagari M. Investigating the Level of Antibiotic Resistance and Detection of Betalactamase of blaTEM High Frequency in the ESBLs Producing E. coli Isolated in Rasht. Sjimu 2014;22:180-189.
  22. Shah AA, Hasan F, Ahmed S, Hameed A. Characteristics, epidemiology and clinical importance of emerging strains of Gram-negative bacilli producing extended-spectrum β-lactamases. Res Microbiol. 2004;155(6):409-21.